Physician profile
Paul L Digiorgi
NPI 1801013404
$665,916.05
in general payments reported to CMS, 2019-2025
35 companies · $203K in 2025
The $203K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $22K · 2021: $30K · 2022: $75K · 2023: $124K · 2024: $189K · 2025: $203K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $446K · Consulting Fee: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $13K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $446,189.01 |
| Consulting Fee | $32,731.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,600.00 |
| Travel and Lodging | $12,689.77 |
| Food and Beverage | $10,530.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $585,042.15 | 2019-2025 | Arthrex, Shoulder Suture Fiberwire Cerclage, Shoulder Implants |
| Atricure, INC. | $35,363.03 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Edwards Lifesciences Corporation | $17,188.17 | 2019-2025 | Konect Resilia, Mitris Resilia Mitral Valve |
| Lsi Solutions INC | $10,338.16 | 2019-2025 | Ram, Cor-Knot, Minirumel |
| Pacira Pharmaceuticals Incorporated | $8,085.31 | 2021-2023 | Exparel |
| Intuitive Surgical, INC. | $2,502.20 | 2020-2022 | |
| Medtronic, INC. | $2,318.72 | 2021-2025 | Corevalve Evolut R, Avalus, Corecath |
| Haemonetics Corporation | $1,595.80 | 2020-2024 | Teg6s Hemostasis System |
| Abbott Laboratories | $473.79 | 2019-2025 | Epic, Triclip |
| Abiomed | $352.34 | 2019-2025 | Impella |
| Coastal Medical Technologies LLC | $349.29 | 2024-2025 | |
| Cgg Medical INC | $333.86 | 2025 | |
| Ethicon US, LLC | $274.11 | 2025 | Vistaseal, Evarrest, Dermabond Prineo |
| Getinge USA Sales, LLC | $225.38 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $222.61 | 2019-2024 | Tagrisso |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $159.57 | 2019-2025 | Giapreza |
| W. L. Gore & Associates, INC. | $159.05 | 2023 | Gore Tag Conformable Thoracic Endoprosthesis |
| Solventum Corporation | $158.15 | 2024-2025 | Prevena |
| Livanova USA, INC. | $120.22 | 2025 | Essenz |
| Kls-Martin L.P. | $88.98 | 2025 | |
| Corcym INC | $83.68 | 2025 | Perceval |
| Irhythm Technologies, INC. | $68.34 | 2019 | |
| Becton, Dickinson and Company | $49.69 | 2025 | Hemosphere |
| Cvrx, INC. | $49.50 | 2025 | Barostim Neo System |
| Zimmer Biomet Holdings, INC. | $46.52 | 2019 | |
| Cardiva Medical, INC. | $42.21 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Savvywire |
| Pfizer INC. | $40.17 | 2022 | |
| Bard Access Systems, INC. | $38.06 | 2019 | |
| Nuwellis, INC. | $29.41 | 2019 | |
| Mvp Orthopedics INC | $27.85 | 2022 | |
| Angiodynamics, INC. | $24.18 | 2025 | Angiovac |
| Mallinckrodt Enterprises LLC | $22.06 | 2019 | |
| Stryker Corporation | $17.25 | 2024 | Na, Stryker Varispeed |
| Philips North America LLC | $15.13 | 2025 | Event |
| Medtronic Vascular, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Digiorgi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.